This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: University of Connecticut, University of Ghent. Active years: 2016.
Company Filing History:
1 out of 780 
1 out of 505 
Years Active: 2016
Title: Martine De Vos: Innovator in Intestinal Inflammation Treatment
Introduction
Martine De Vos is a notable inventor based in De Pinte, Belgium. He has made significant contributions to the field of medical research, particularly in the treatment of intestinal inflammation. His innovative approach focuses on the use of antagonists targeting metallothionein, a type of protein that plays a crucial role during inflammatory responses.
Latest Patents
Martine De Vos holds a patent for the "Use of antagonists targeting metallothionein to treat intestinal inflammation." This patent highlights the potential of antagonizing metallothioneins during gut inflammation to reduce markers of inflammation and enhance recovery. His work emphasizes the importance of metallothioneins in modulating inflammatory processes.
Career Highlights
Throughout his career, Martine De Vos has been associated with prestigious institutions such as Ghent University and the University of Connecticut. His research has contributed to a deeper understanding of the mechanisms involved in intestinal inflammation and has opened new avenues for therapeutic interventions.
Collaborations
Martine has collaborated with several professionals in his field, including Debby Laukens and Lindsey DeVisscher. These collaborations have enriched his research and have fostered a collaborative environment for innovation.
Conclusion
Martine De Vos is a pioneering inventor whose work on metallothionein antagonists has the potential to transform the treatment of intestinal inflammation. His contributions to medical research continue to inspire advancements in therapeutic strategies.